You are here

  • Home
  • Archive
  • Volume 72, Issue 1
  • Systemically administered interferon alfa-2a prevents recurrence of condylomata acuminata following CO2-laser ablation. The influence of the cyclic low-dose therapy regimen. Results of a multicentre double-blind placebo-controlled clinical trial.

Citation Tools

Article menu
Download PDFPDF
Research Article
Systemically administered interferon alfa-2a prevents recurrence of condylomata acuminata following CO2-laser ablation. The influence of the cyclic low-dose therapy regimen. Results of a multicentre double-blind placebo-controlled clinical trial.

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Gross G, Roussaki A, Baur S, et al
Systemically administered interferon alfa-2a prevents recurrence of condylomata acuminata following CO2-laser ablation. The influence of the cyclic low-dose therapy regimen. Results of a multicentre double-blind placebo-controlled clinical trial.
Sexually Transmitted Infections 1996;72:71.